CDTX - Cidara Therapeutics, Inc.

QQQ $ 595.45 $ 0.00 (0 %)

DIA $ 464.06 $ 0.00 (0 %)

SPY $ 663.05 $ 0.00 (0 %)

TLT $ 89.78 $ 0.00 (0 %)

GLD $ 375.50 $ 0.00 (0 %)

Previous Close

$ 219.35

Open

$ 219.45

Bid

$ 218.38 x 17

Ask

$ 219.74 x 100

Day's Range

-- - --

52 Week Range

$ 15.22 - $ 220.41

Volume

1,312,892

Average Volume

Market Cap

6.9B

Beta (5Y Monthly)

$ 1.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-06-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-15-2024	03-31-2024	10-Q
8	04-22-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	03-07-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-12-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	02-25-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-13-2020	06-30-2020	10-Q
23	05-13-2020	03-31-2020	10-Q
24	03-04-2020	12-31-2019	10-K
25	11-08-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	02-28-2019	12-31-2018	10-K
29	11-08-2018	09-30-2018	10-Q
30	08-09-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	02-27-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	03-15-2017	12-31-2016	10-K
37	11-10-2016	09-30-2016	10-Q
38	08-11-2016	06-30-2016	10-Q
39	05-12-2016	03-31-2016	10-Q
40	03-18-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cidara Therapeutics Reaches Target Enrollm...
11/24/2025 13:08:10

Target enrollment of 6,000 participants completed in the Northern HemispherePlanned interim analysis in Q1 2026 will determine ...

pfizers-new-mrna-flu-vaccine-outperforms-traditional-shot-against-predominant-strains

Pfizer's New mRNA Flu Vaccine Outperforms ...
11/21/2025 15:48:57

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.

Guggenheim Downgrades Cidara Therapeutics ...
11/18/2025 14:06:21

Guggenheim analyst Seamus Fernandez downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Neutral.

top-2-health-care-stocks-that-may-fall-off-a-cliff-this-month

Top 2 Health Care Stocks That May Fall Off...
11/17/2025 13:15:43

HC Wainwright & Co. Downgrades Cidara Ther...
11/14/2025 19:34:04

HC Wainwright & Co. analyst Sara Nik downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Neutral.

Needham Downgrades Cidara Therapeutics to ...
11/14/2025 18:52:51

Needham analyst Joseph Stringer downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Hold.

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
11/14/2025 17:06:24

gold-tumbles-over-2-cidara-therapeutics-shares-spike-higher

Gold Tumbles Over 2%; Cidara Therapeutics ...
11/14/2025 17:02:21

legence-cidara-therapeutics-avadel-pharmaceuticals-omeros-and-other-big-stocks-moving-higher-on-friday

Legence, Cidara Therapeutics, Avadel Pharm...
11/14/2025 14:54:48

nasdaq-dips-over-300-points-applied-materials-posts-upbeat-q4-earnings

Nasdaq Dips Over 300 Points; Applied Mater...
11/14/2025 14:42:17

merck-makes-big-bet-on-flu-protection-with-cidara-buyout

Merck Makes Big Bet On Flu Protection With...
11/14/2025 14:32:24

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
11/14/2025 12:06:17

Merck Bulks Up Respiratory Portfolio With ...
11/14/2025 11:48:05

Merck To Acquire Cidara Therapeutics For $...
11/14/2025 11:47:27

Financial Times Reported Merck Nears $9.2B...
11/14/2025 11:02:13

https://www.ft.com/content/743e1962-3dd1-4785-a20b-4b097e5514ae

why-rlx-technology-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket

Why RLX Technology Shares Are Trading High...
11/14/2025 10:52:19

why-is-cidara-therapeutics-cdtx-stock-trending-overnight

Why Is Cidara Therapeutics (CDTX) Stock Tr...
11/14/2025 05:56:00

Cidara Therapeutics shares jumped over 42% in after-hours trading following a 13D filing and Phase 3 enrollment milestone.

RBC Capital Maintains Outperform on Cidara...
11/07/2025 18:48:28

RBC Capital analyst Brian Abrahams maintains Cidara Therapeutics (NASDAQ:CDTX) with a Outperform and raises the price target...

Needham Maintains Buy on Cidara Therapeuti...
11/07/2025 10:12:55

Needham analyst Joseph Stringer maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and raises the price target from $100...

UPDATE: Cidara Therapeutics Q3 Adj. EPS $(...
11/06/2025 22:55:34

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of...